Advertisement
    In the last 4 hours
    Yesterday
    In the last 7 days
    Chandimandir joins elite Army cancer care network The Times of India20:25 7-Sept-26
    Bracco expands BubbleGen Cell Selection with CD3+ T Cell Isolation Kit European Pharmaceutical Manufacturer13:15 7-Sept-26
    In the last month
    Liminatus Pharma selects Synex to advance CAR-T trial Clinical Trials Arena16:30 25-Aug-26
    Cell-preservation technique could make CAR-T cell therapy more accessible Massachusetts Institute of Technology05:02 19-Aug-26
    view more headlines
    14 Sept 12:31

    About our CAR-T news

    Latest news on CAR-T (Chimeric Antigen Receptor T-cell) therapy, a type of cancer treatment that involves modifying patients' T-cells to recognize and attack cancer cells. In this therapy, T-cells are collected from the patient, engineered in a lab to express a specific receptor that binds to a protein on cancer cells, and then infused back into the patient to fight the cancer. CAR-T therapies have shown promise in treating certain types of blood cancers, like lymphoma and leukemia.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.